Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 2 Experimental protocols to investigate effects of immediate or delayed treatment with erythropoietin (EPO) on neovascularization and cardiac function. CD34+MNC = CD34-positive mononuclear cell; other abbreviations as in Figure 1.
|
